The study focused on the evaluation of β3-AR expression on total cells and on CD45−CD99+ cancer cells present in PB and on the analysis of the association with the clinical status of the patient (localized disease, metastatic disease, relapse, or remission). The gene discussed is ADRB3; the disease is cancer.